Dry Powder Inhalers
Investigation of electrostatic charging phenomena in dry powder inhalers and the effect on deposition
209
Evaluation study of dry powder inhalers: a concise, systematic review
6
In vitro dose comparison of Respimat<sup>®</sup> inhaler with dry powder inhalers for COPD maintenance therapy
13
Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation
15
Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD
11
Patients’ usability of seven most used dry-powder inhalers in COPD
9
Particle size measurement of lactose for dry powder inhalers
6
Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials
8
Particle engineering of materials for oral inhalation by dry powder inhalers I Particles of sugar excipients (trehalose and raffinose) for protein delivery
45
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study
14
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β<sub>2</sub>-agonist via dry-powder inhalers and pressurized metered-dose inhalers
14
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
8
Asthma control in patients receiving inhaled corticosteroid and long acting beta2 agonist fixed combinations A real life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
8
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
8
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
11
Drug Delivery to the Respiratory Tract Using Dry Powder Inhalers
230
Dry-powder inhalers in patients with persistent airflow limitation: usability and preference
9
Particle engineering of materials for oral inhalation by dry powder inhalers II Sodium cromoglicate
48
Appropriate use of a dry powder inhaler based on inhalation flow pattern
7
Need of education for dry powder inhaler storage and retention – a patient-reported survey
5